RXi Pharmaceuticals Corporation (RXII) tumbled -48.71% or -0.57 to $0.6. It is approximately 3.12 million shares traded, which is 1056.4% compare to the average total volume 294891. The market cap of RXII is $2.64 million. The year to date change is -127.44%. The 52 week price range is from $0.58 to $7.7. Price of RXII have changed -1.68% during last week. It have changed -19.86% over last month, -44.02% over last 3 months, -67.13% over last 6 months and -75.63% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 1.49. It is 148.33% above current price. The 200-day Moving Averages for RXII is 2.85. It is 375.00% above current price. The 52-week High is 7.7. It is 1183.33% from the current price. The 52-week Low is 0.58. It is -3.33% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 9.12 on 2018-09-14. Short % to float is 19.10%. There are some statistics of RXII. It is has market cap $2.64 million. The share outstanding is 4.40 million. The average volume is 294891. The percent of top 15 Institution holding is 35.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -184.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -117.95%.